{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:26:28Z","timestamp":1792787188504,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T00:00:00Z","timestamp":1608508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T00:00:00Z","timestamp":1608508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["13N13766"],"award-info":[{"award-number":["13N13766"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>The treatment guidelines for many macular diseases rely on frequent monitoring with optical coherence tomography (OCT). However, the burden of frequent disease control leads to low therapy adherence in real life. OCT home monitoring would address this issue but requires an inexpensive and self-operable device. With self-examination low-cost full-field OCT (SELFF-OCT), our group has introduced a novel technology that may fulfill both requirements. In this pilot study, we report the initial experiences with a clinical prototype.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Fifty-one patients with different macular diseases were recruited in a cross-sectional study. The most common diseases were age-related macular degeneration (AMD; 39\/51), diabetic macular edema (DME; 6\/51), and retinal vein occlusion (RVO; 3\/51). Patients received a short training in device usage and then performed multiple self-scans with the SELFF-OCT device. For comparison, scans with a standard clinical spectral domain (SD-)OCT were taken.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After a brief training, 77% of the patients were able to successfully acquire images that were clinically gradable. No significant influence on success could be found for age (<jats:italic>p<\/jats:italic>\u2009=\u20090.08) or BCVA (<jats:italic>p<\/jats:italic>\u2009=\u20090.97). Relevant disease biomarkers in the most common retinal diseases could be detected.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>SELFF-OCT was used successfully for retinal self-examination and in the future could be used for retinal home monitoring. Future improvements in technology are expected to improve success rates and image quality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The Trial was registered in the German Trial Register under the number DRKS00013755 on 14.03.2018.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00417-020-05035-6","type":"journal-article","created":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T12:02:32Z","timestamp":1608552152000},"page":"1503-1511","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Self-examination low-cost full-field OCT (SELFF-OCT) for patients with various macular diseases"],"prefix":"10.1007","volume":"259","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2163-5905","authenticated-orcid":false,"given":"Claus","family":"von der Burchard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Moltmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Tode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Ehlken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helge","family":"Sudkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Theisen-Kunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inke","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gereon","family":"H\u00fcttmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Roider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,21]]},"reference":[{"key":"5035_CR1","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00347-006-1381-0","volume":"103","author":"C Klatt","year":"2006","unstructured":"Klatt C, Sendtner P, Ponomareva L et al (2006) Diagnostics of metamorphopsia in retinal diseases of different origins. Ophthalmologe 103:945\u2013952. https:\/\/doi.org\/10.1007\/s00347-006-1381-0","journal-title":"Ophthalmologe"},{"key":"5035_CR2","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s00417-018-4021-x","volume":"256","author":"M-C Bruender","year":"2018","unstructured":"Bruender M-C, Benjamin N, Agostini HT et al (2018) Subjective evaluation of visual acuity is not reliable to detect disease activity in different exudative maculopathies. Graefes Arch Clin Exp Ophthalmol 256:1565\u20131571. https:\/\/doi.org\/10.1007\/s00417-018-4021-x","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5035_CR3","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.jfo.2019.02.017","volume":"42","author":"C Chamard","year":"2019","unstructured":"Chamard C, Lacombe S, Navarre S et al (2019) Is current age related macular degeneration self-monitoring a good tool for detecting exudative recurrence? J Fr Ophtalmol 42:1049\u20131055. https:\/\/doi.org\/10.1016\/j.jfo.2019.02.017","journal-title":"J Fr Ophtalmol"},{"key":"5035_CR4","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1136\/bjophthalmol-2014-305,702","volume":"98","author":"U Schmidt-Erfurth","year":"2014","unstructured":"Schmidt-Erfurth U, Chong V, Loewenstein A et al (2014) Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). Br J Ophthalmol 98:1144\u20131167. https:\/\/doi.org\/10.1136\/bjophthalmol-2014-305,702","journal-title":"Br J Ophthalmol"},{"key":"5035_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000502041","volume":"242","author":"U Schmidt-Erfurth","year":"2019","unstructured":"Schmidt-Erfurth U, Garcia-Arumi J, Gerendas BS et al (2019) Guidelines for the management of retinal vein occlusion by the European Society of Retina Specialists (EURETINA). Ophthalmologica 242:123\u2013162. https:\/\/doi.org\/10.1159\/000502041","journal-title":"Ophthalmologica"},{"key":"5035_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000458539","volume":"237","author":"U Schmidt-Erfurth","year":"2017","unstructured":"Schmidt-Erfurth U, Garcia-Arumi J, Bandello F et al (2017) Guidelines for the management of diabetic macular edema by the European Society of Retina Specialists (EURETINA). Ophthalmologica 237:185\u2013222. https:\/\/doi.org\/10.1159\/000458539","journal-title":"Ophthalmologica"},{"key":"5035_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/bjophthalmol-2016-308,668","volume":"101","author":"T Wecker","year":"2017","unstructured":"Wecker T, Ehlken C, B\u00fchler A et al (2017) Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV. Br J Ophthalmol 101:353\u2013359. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-308,668","journal-title":"Br J Ophthalmol"},{"key":"5035_CR8","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.oret.2016.12.004","volume":"1","author":"CC Wykoff","year":"2017","unstructured":"Wykoff CC, Ou WC, Brown DM et al (2017) Randomized trial of treat-and-extend versus monthly dosing for neovascular age-related macular degeneration: 2-year results of the TREX-AMD study. Ophthalmol Retina 1:314\u2013321. https:\/\/doi.org\/10.1016\/j.oret.2016.12.004","journal-title":"Ophthalmol Retina"},{"key":"5035_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ajo.2017.09.027","volume":"185","author":"MA Windsor","year":"2018","unstructured":"Windsor MA, Sun SJJ, Frick KD et al (2018) Estimating public and patient savings from basic research-a study of optical coherence tomography in managing antiangiogenic therapy. Am J Ophthalmol 185:115\u2013122. https:\/\/doi.org\/10.1016\/j.ajo.2017.09.027","journal-title":"Am J Ophthalmol"},{"key":"5035_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/OPTH.S151611","volume":"12","author":"C Ehlken","year":"2018","unstructured":"Ehlken C, Helms M, B\u00f6hringer D et al (2018) Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients. Clin Ophthalmol 12:13\u201320. https:\/\/doi.org\/10.2147\/OPTH.S151611","journal-title":"Clin Ophthalmol"},{"key":"5035_CR11","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.1364\/OL.41.004987","volume":"41","author":"H Sudkamp","year":"2016","unstructured":"Sudkamp H, Koch P, Spahr H et al (2016) In-vivo retinal imaging with off-axis full-field time-domain optical coherence tomography. Opt Lett 41:4987\u20134990. https:\/\/doi.org\/10.1364\/OL.41.004987","journal-title":"Opt Lett"},{"key":"5035_CR12","first-page":"36","volume":"11","author":"M Abramoff","year":"2003","unstructured":"Abramoff M, Magalh\u00e3es P, Ram SJ (2003) Image processing with ImageJ. Biophoton Int 11:36\u201342","journal-title":"Biophoton Int"},{"key":"5035_CR13","unstructured":"R Core Team (2018) R: a language and environment for statistical computing. https:\/\/www.R-project.org\/. Accessed 22 Oct 2019"},{"key":"5035_CR14","unstructured":"Schauberger P, Walker A, Braglia L (2018) openxlsx: Read, Write and Edit XLSX Files. https:\/\/CRAN.R-project.org\/package=openxlsx. Accessed 22 Oct 2019"},{"key":"5035_CR15","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1364\/OL.43.004224","volume":"43","author":"H Sudkamp","year":"2018","unstructured":"Sudkamp H, Hillmann D, Koch P et al (2018) Simple approach for aberration-corrected OCT imaging of the human retina. Opt Lett 43:4224. https:\/\/doi.org\/10.1364\/OL.43.004224","journal-title":"Opt Lett"},{"key":"5035_CR16","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s00417-018-4040-7","volume":"256","author":"C von der Burchard","year":"2018","unstructured":"von der Burchard C, Treumer F, Ehlken C et al (2018) Retinal volume change is a reliable OCT biomarker for disease activity in neovascular AMD. Graefes Arch Clin Exp Ophthalmol 256:1623\u20131629. https:\/\/doi.org\/10.1007\/s00417-018-4040-7","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"5035_CR17","unstructured":"von der Burchard CC, Tode J, Ehlken C, Roider J (2017) 2mm central macular volume scan is sufficient to detect exudative age-related macular degeneration activity in optical coherence tomography. Invest Ophthalmol Vis Sci 58:374\u2013374."},{"key":"5035_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00347-014-3222-x","volume":"112","author":"Deutsche Ophthalmologische Gesellschaft","year":"2015","unstructured":"Deutsche Ophthalmologische Gesellschaft (2015) Die Anti-VEGF-Therapie bei der neovaskul\u00e4ren altersabh\u00e4ngigen Makuladegeneration \u2013 therapeutische Strategien: Stellungnahme der Deutschen Ophthalmologischen Gesellschaft, der Retinologischen Gesellschaft und des Berufsverbandes der Augen\u00e4rzte Deutschlands \u2013 November 2014. Ophthalmologe 112:237\u2013245. https:\/\/doi.org\/10.1007\/s00347-014-3222-x","journal-title":"Ophthalmologe"},{"key":"5035_CR19","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.jfo.2014.11.015","volume":"38","author":"E Boulanger-Scemama","year":"2015","unstructured":"Boulanger-Scemama E, Querques G, About F et al (2015) Ranibizumab for exudative age-related macular degeneration: a five year study of adherence to follow-up in a real-life setting. J Fr Ophtalmol 38:620\u2013627. https:\/\/doi.org\/10.1016\/j.jfo.2014.11.015","journal-title":"J Fr Ophtalmol"},{"key":"5035_CR20","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1097\/IAE.0000000000000627","volume":"35","author":"KB Freund","year":"2015","unstructured":"Freund KB, Korobelnik J-F, Devenyi R et al (2015) Treat-and-extend regimens with anti-VEGF agents in retinal diseases: a literature review and consensus recommendations. Retina (Philadelphia, Pa) 35:1489\u20131506. https:\/\/doi.org\/10.1097\/IAE.0000000000000627","journal-title":"Retina (Philadelphia, Pa)"},{"key":"5035_CR21","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1097\/IAE.0000000000000134","volume":"34","author":"F Abedi","year":"2014","unstructured":"Abedi F, Wickremasinghe S, Islam AFM et al (2014) Anti-VEGF treatment in neovascular age\u2013related macular degeneration: a treat-and-extend protocol over 2\u00a0years. Retina 34:1531. https:\/\/doi.org\/10.1097\/IAE.0000000000000134","journal-title":"Retina"},{"key":"5035_CR22","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1167\/tvst.8.3.61","volume":"8","author":"G Song","year":"2019","unstructured":"Song G, Chu KK, Kim S et al (2019) First clinical application of low-cost OCT. Transl Vis Sci Technol 8:61. https:\/\/doi.org\/10.1167\/tvst.8.3.61","journal-title":"Transl Vis Sci Technol"},{"key":"5035_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1167\/tvst.7.4.8","volume":"7","author":"P Maloca","year":"2018","unstructured":"Maloca P, Hasler PW, Barthelmes D et al (2018) Safety and feasibility of a novel sparse optical coherence tomography device for patient-delivered retina home monitoring. Transl Vis Sci Technol 7:8. https:\/\/doi.org\/10.1167\/tvst.7.4.8","journal-title":"Transl Vis Sci Technol"},{"key":"5035_CR24","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1167\/iovs.18-26252","volume":"60","author":"O Tomkins-Netzer","year":"2019","unstructured":"Tomkins-Netzer O, Elman MJ (2019) Comparison between retinal images captured by a self-operated, home-based optical coherence tomography (OCT) system and commercial OCT systems. Invest Ophthalmol Vis Sci 60:1898\u20131898","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5035_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1117\/12.2526903","volume-title":"Optical Coherence Imaging Techniques and Imaging in Scattering Media III","author":"EA Rank","year":"2019","unstructured":"Rank EA, Nevlacsil S, Muellner P et al (2019) Spectral domain and swept source optical coherence tomography on a photonic integrated circuit at 840nm for ophthalmic application. In: Boppart SA, Wojtkowski M, Oh W-Y (eds) Optical Coherence Imaging Techniques and Imaging in Scattering Media III. SPIE, Munich, Germany, p 29"},{"key":"5035_CR26","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/s41591-018-0107-6","volume":"24","author":"J De Fauw","year":"2018","unstructured":"De Fauw J, Ledsam JR, Romera-Paredes B et al (2018) Clinically applicable deep learning for diagnosis and referral in retinal disease. Nat Med 24:1342\u20131350. https:\/\/doi.org\/10.1038\/s41591-018-0107-6","journal-title":"Nat Med"},{"key":"5035_CR27","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1364\/BOE.10.003484","volume":"10","author":"T Kepp","year":"2019","unstructured":"Kepp T, Droigk C, Casper M et al (2019) Segmentation of mouse skin layers in optical coherence tomography image data using deep convolutional neural networks. Biomed Opt Express 10:3484\u20133496. https:\/\/doi.org\/10.1364\/BOE.10.003484","journal-title":"Biomed Opt Express"},{"key":"5035_CR28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1117\/12.2551324","volume-title":"Medical Imaging 2020: Computer-Aided Diagnosis","author":"T Kepp","year":"2020","unstructured":"Kepp T, Sudkamp H, von der Burchard C et al (2020) Segmentation of retinal low-cost optical coherence tomography images using deep learning. In: Hahn HK, Mazurowski MA (eds) Medical Imaging 2020: Computer-Aided Diagnosis. SPIE, Houston, United States, p 56"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-05035-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-020-05035-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-020-05035-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T10:16:03Z","timestamp":1622456163000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-020-05035-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,21]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["5035"],"URL":"https:\/\/doi.org\/10.1007\/s00417-020-05035-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,21]]},"assertion":[{"value":"24 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Helge Sudkamp, Peter Koch, Michael M\u00fcnst, and Gereon H\u00fcttmann hold a patent for the technology described in this paper. Moritz Moltmann, Helge Sudkamp, Peter Koch, and Michael M\u00fcnst have invested in a company that is currently developing the technology further.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Kiel Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients signed an informed consent sheet before entering the trial.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The informed consent sheet specified that the results of the trial including acquired images can be published.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}